Veeva Systems Free Cash Flow 2012-2024 | VEEV
Veeva Systems annual/quarterly free cash flow history and growth rate from 2012 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Veeva Systems free cash flow for the quarter ending October 31, 2024 was 1,004.71, a year-over-year.
- Veeva Systems free cash flow for the twelve months ending October 31, 2024 was , a year-over-year.
- Veeva Systems annual free cash flow for 2024 was $0.885B, a 15.41% increase from 2023.
- Veeva Systems annual free cash flow for 2023 was $0.767B, a 2.23% increase from 2022.
- Veeva Systems annual free cash flow for 2022 was $0.75B, a 38.28% increase from 2021.
| Veeva Systems Annual Free Cash Flow | |
|---|---|
| 2024 | 885.14 |
| 2023 | 766.96 |
| 2022 | 750.25 |
| 2021 | 542.56 |
| 2020 | 433.05 |
| 2019 | 301.01 |
| 2018 | 222.07 |
| 2017 | 136.50 |
| 2016 | 58.57 |
| 2015 | 40.63 |
| 2014 | 38.78 |
| 2013 | 29.25 |
| 2012 | 3.54 |
| 2011 | 4.32 |
| Veeva Systems Quarterly Free Cash Flow | |
|---|---|
| 2024-10-31 | 1,004.71 |
| 2024-07-31 | 844.86 |
| 2024-04-30 | 755.04 |
| 2024-01-31 | 885.14 |
| 2023-10-31 | 835.11 |
| 2023-07-31 | 758.42 |
| 2023-04-30 | 502.98 |
| 2023-01-31 | 766.96 |
| 2022-10-31 | 707.47 |
| 2022-07-31 | 570.42 |
| 2022-04-30 | 478.69 |
| 2022-01-31 | 750.25 |
| 2021-10-31 | 700.11 |
| 2021-07-31 | 589.47 |
| 2021-04-30 | 475.73 |
| 2021-01-31 | 542.56 |
| 2020-10-31 | 474.44 |
| 2020-07-31 | 382.35 |
| 2020-04-30 | 282.44 |
| 2020-01-31 | 433.05 |
| 2019-10-31 | 394.04 |
| 2019-07-31 | 333.77 |
| 2019-04-30 | 234.68 |
| 2019-01-31 | 301.01 |
| 2018-10-31 | 272.39 |
| 2018-07-31 | 235.49 |
| 2018-04-30 | 149.65 |
| 2018-01-31 | 222.07 |
| 2017-10-31 | 222.54 |
| 2017-07-31 | 192.24 |
| 2017-04-30 | 137.41 |
| 2017-01-31 | 136.50 |
| 2016-10-31 | 141.49 |
| 2016-07-31 | 117.98 |
| 2016-04-30 | 107.16 |
| 2016-01-31 | 58.57 |
| 2015-10-31 | 57.47 |
| 2015-07-31 | 42.29 |
| 2015-04-30 | 37.06 |
| 2015-01-31 | 40.63 |
| 2014-10-31 | 42.62 |
| 2014-07-31 | 9.24 |
| 2014-04-30 | 17.61 |
| 2014-01-31 | 38.78 |
| 2013-10-31 | 22.95 |
| 2013-07-31 | 18.87 |
| 2013-04-30 | 12.81 |
| 2013-01-31 | |
| 2012-10-31 | 22.51 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $37.870B | $2.364B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.036B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.145B | 207.11 |
| Inspire Medical Systems (INSP) | United States | $5.799B | 180.84 |
| IRhythm Technologies (IRTC) | United States | $3.407B | 0.00 |
| Privia Health (PRVA) | United States | $2.742B | 228.50 |
| Enovis (ENOV) | United States | $2.671B | 17.80 |
| Azenta (AZTA) | United States | $2.470B | 131.83 |
| Clover Health Investments (CLOV) | United States | $2.200B | 0.00 |
| Omnicell (OMCL) | United States | $2.084B | 68.17 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| 10x Genomics (TXG) | United States | $1.816B | 0.00 |
| Phreesia (PHR) | United States | $1.654B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.850B | 0.00 |
| Standard BioTools (LAB) | United States | $0.577B | 0.00 |
| Talkspace (TALK) | United States | $0.524B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.509B | 0.00 |
| TruBridge (TBRG) | United States | $0.370B | 107.91 |
| Nyxoah SA (NYXH) | Belgium | $0.368B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| Pulmonx (LUNG) | United States | $0.224B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.056B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |